Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on: May 20,2024

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on:May 20,2024

New treatments for Alzheimer's and stroke revealed in several new studies

by American Physiological SocietyCredit: Pixabay/CC0 Public DomainThe results of three new studies indicate there could be new treatments for Alzheimer's and stroke. One study reveals a possi

Updated on: June 18,2024

New treatments for Alzheimer's and stroke revealed in several new studies

by American Physiological SocietyCredit: Pixabay/CC0 Public DomainThe results of three new studies indicate there could be new treatments for Alzheimer's and stroke. One study reveals a possi

Updated on:June 18,2024

International study uncovers a molecule that could alleviate stroke-related brain injury

byThe Hospital for Sick ChildrenCredit: CC0 Public DomainA newly developed molecule, LK-2, could inform new therapies for stroke-related brain injury, find scientists at The Hospital for Sick Ch

Updated on: July 17,2024

International study uncovers a molecule that could alleviate stroke-related brain injury

byThe Hospital for Sick ChildrenCredit: CC0 Public DomainA newly developed molecule, LK-2, could inform new therapies for stroke-related brain injury, find scientists at The Hospital for Sick Ch

Updated on:July 17,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on: March 30,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on:March 30,2024

Depression best treated by nonpharmacological approaches in people living with dementia

by University of New South WalesCredit: Pixabay/CC0 Public DomainResearch led by UNSW Sydney's Center for Healthy Brain Aging (CHeBA) has confirmed treating symptoms of depression is most eff

Updated on: May 06,2024

Depression best treated by nonpharmacological approaches in people living with dementia

by University of New South WalesCredit: Pixabay/CC0 Public DomainResearch led by UNSW Sydney's Center for Healthy Brain Aging (CHeBA) has confirmed treating symptoms of depression is most eff

Updated on:May 06,2024

Not just a 'bad guy': Researchers discover neuroprotective function of Tau protein

by Rajalaxmi Natarajan,Baylor College of MedicineOverexpression of hTau in glia disrupts LDs and glial cell morphology in response to neuronal ROS. Credit:Nature Neuroscience(2024).

Updated on: September 06,2024

Not just a 'bad guy': Researchers discover neuroprotective function of Tau protein

by Rajalaxmi Natarajan,Baylor College of MedicineOverexpression of hTau in glia disrupts LDs and glial cell morphology in response to neuronal ROS. Credit:Nature Neuroscience(2024).

Updated on:September 06,2024

Disruption of brain-blood barrier might influence progression of Alzheimer's

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.More and more data from preclinical and clinical st

Updated on: February 26,2024

Disruption of brain-blood barrier might influence progression of Alzheimer's

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.More and more data from preclinical and clinical st

Updated on:February 26,2024

Brain activity differentiates between types of social influence

by Public Library of ScienceDistinct role of dACC in human-human and human-AI interactions. Credit: Bahador Bahrami (CC-BY 4.0, creativecommons.org/licenses/by/4.0/)Researchers led by Ali Mahmood

Updated on: February 21,2024

Brain activity differentiates between types of social influence

by Public Library of ScienceDistinct role of dACC in human-human and human-AI interactions. Credit: Bahador Bahrami (CC-BY 4.0, creativecommons.org/licenses/by/4.0/)Researchers led by Ali Mahmood

Updated on:February 21,2024

New biomarker for dementia diagnosis

by Flinders UniversityProfessor Arduino Mangoni, Head of Clinical Pharmacology at Flinders University, in his research laboratory in South Australia. Credit: Flinders UniversityMedical researcher

Updated on: May 11,2024

New biomarker for dementia diagnosis

by Flinders UniversityProfessor Arduino Mangoni, Head of Clinical Pharmacology at Flinders University, in his research laboratory in South Australia. Credit: Flinders UniversityMedical researcher

Updated on:May 11,2024

Imaging of a living brain can help clearly differentiate between two types of dementia

by Champalimaud Centre for the UnknownSPECT images, superimposed on a magnetic resonance atlas, of an axial slice (top row) and a sagittal slice (bottom row) of the human brain, with a quantitative ar

Updated on: June 11,2024

Imaging of a living brain can help clearly differentiate between two types of dementia

by Champalimaud Centre for the UnknownSPECT images, superimposed on a magnetic resonance atlas, of an axial slice (top row) and a sagittal slice (bottom row) of the human brain, with a quantitative ar

Updated on:June 11,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on: April 16,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on:April 16,2024

Pilot study shows promise for remote cognitive rehabilitation for multiple sclerosis patients

by Kessler FoundationCredit: Anna Shvets from PexelsA pilot study shows promise for a new treatment option for individuals with memory impairments caused by multiple sclerosis (MS). Thearticle,

Updated on: July 08,2024

Pilot study shows promise for remote cognitive rehabilitation for multiple sclerosis patients

by Kessler FoundationCredit: Anna Shvets from PexelsA pilot study shows promise for a new treatment option for individuals with memory impairments caused by multiple sclerosis (MS). Thearticle,

Updated on:July 08,2024